New DNA therapy tested in 8 patients with advanced cancer
Disease control
Completed
This early-phase study tested a new DNA-based treatment called SXRN in 8 people with advanced solid tumors who had no other standard options. The main goal was to check safety and find the best dose, not to cure the cancer. The treatment aims to control the disease, but patients …
Phase: EARLY_PHASE1 • Sponsor: Jiangsu Nutai Biologics Co., Ltd • Aim: Disease control
Last updated May 14, 2026 12:04 UTC